ENTRY       D09566                      Drug
NAME        Linagliptin (JAN/USAN/INN);
            Tradjenta (TN)
PRODUCT     TRADJENTA (Boehringer Ingelheim Pharmaceuticals)
            TRADJENTA (Cardinal Health 107)
FORMULA     C25H28N8O2
EXACT_MASS  472.2335
MOL_WEIGHT  472.5422
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG01601  DPP-4 inhibitor
REMARK      Therapeutic category: 3969
            ATC code: A10BH05
            Chemical structure group: DG03274
            Product (DG03274): D09566<JP/US>
            Product (mixture): D10264<US> D10588<JP/US> D11856<US>
EFFICACY    Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
COMMENT     Treatment of type 2 diabetes
TARGET      DPP4 (CD26) [HSA:1803] [KO:K01278]
  PATHWAY   hsa04974(1803)  Protein digestion and absorption
INTERACTION  
STR_MAP     map07051  Antidiabetics
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
                 A10BH05 Linagliptin
                  D09566  Linagliptin (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Agents
               Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
                Linagliptin
                 D09566  Linagliptin (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               396  Antidiabetic agents
                3969  Others
                 D09566  Linagliptin (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG01601  DPP-4 inhibitor
                DG03274  Linagliptin
                 D09566  Linagliptin
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG01601  DPP-4 inhibitor
               D09566  Linagliptin
              DG02044  Hypoglycemic agent
               D09566  Linagliptin
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Peptidyl-peptidases
                DPP4 (CD26)
                 D09566  Linagliptin (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09566
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09566
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D09566
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09566
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG01601  DPP-4 inhibitor
                DG03274  Linagliptin
DBLINKS     CAS: 668270-12-0
            PubChem: 124490306
            ChEBI: 68610
            PDB-CCD: 356
            LigandBox: D09566
ATOM        35
            1   C8x C    15.6073  -25.1957
            2   C8x C    15.6073  -26.5954
            3   C8x C    16.7971  -27.2953
            4   C8y C    18.1269  -26.5954
            5   C8y C    18.1269  -25.1957
            6   C8x C    16.7971  -24.4958
            7   C8y C    19.3167  -27.2953
            8   N5x N    20.5065  -26.5954
            9   C8y C    20.5065  -25.1957
            10  N5x N    19.3167  -24.4958
            11  C1a C    19.3167  -28.6950
            12  C1b C    21.6963  -24.4958
            13  N4y N    22.8860  -25.1957
            14  C8y C    22.8860  -26.5954
            15  N4y N    24.1458  -27.2953
            16  C8y C    25.3356  -26.5954
            17  C8y C    25.3356  -25.1957
            18  C8y C    24.1458  -24.4958
            19  O5x O    24.1458  -23.0960
            20  O5x O    21.6963  -27.2953
            21  C1a C    24.1458  -28.6950
            22  N5x N    26.6654  -27.0153
            23  C8y C    27.5053  -25.8955
            24  N4y N    26.6654  -24.7757
            25  N1y N    28.9050  -25.8955
            26  C1x C    29.6049  -27.0853
            27  C1y C    31.0046  -27.0853
            28  C1x C    31.7045  -25.8955
            29  C1x C    31.0046  -24.7057
            30  C1x C    29.6049  -24.7057
            31  N1a N    31.7045  -28.3451
            32  C1b C    27.3653  -23.5859
            33  C3b C    28.7650  -23.5859
            34  C3b C    30.1648  -23.5859
            35  C1a C    31.5646  -23.5859
BOND        39
            1     1   2 1
            2     2   3 2
            3     3   4 1
            4     4   5 2
            5     5   6 1
            6     1   6 2
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 2
            11    5  10 1
            12    7  11 1
            13    9  12 1
            14   12  13 1
            15   13  14 1
            16   14  15 1
            17   15  16 1
            18   16  17 2
            19   17  18 1
            20   13  18 1
            21   18  19 2
            22   14  20 2
            23   15  21 1
            24   16  22 1
            25   22  23 2
            26   23  24 1
            27   17  24 1
            28   23  25 1
            29   25  26 1
            30   26  27 1
            31   27  28 1
            32   28  29 1
            33   29  30 1
            34   25  30 1
            35   27  31 1 #Up
            36   32  33 1
            37   32  24 1
            38   33  34 3
            39   34  35 1
///
